Literature DB >> 23124725

Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study).

Čedo Miljević1, Aleksandra Nikolić-Kokić, Milan Nikolić, Vesna Niketić, Mihajlo B Spasić, Dušica Lečić-Toševski, Duško Blagojević.   

Abstract

OBJECTIVE: This study was set out to examine the impact of atypical antipsychotic drugs: aripiprazole, clozapine, ziprasidone, olanzapine, quetiapine, sertindole and amisulpride on the activity of antioxidant defence enzymes in human erythrocytes in vitro.
METHODS: Cu,Zn-superoxide dismutase (SOD1), catalase (CAT), selenium-dependent glutathione peroxidase and glutathione reductase activities were determined after drugs incubation with blood of 15 apparently healthy non-smoking male volunteers (ages 23-39) for 1 h at 37 °C.
RESULTS: A statistically significant increase in SOD1 activity was found in samples incubated with aripiprazole (p < 0.01) and quetiapine (p < 0.05) compared with incubated control. SOD1 activity profile following native polyacrylamide gel electrophoresis indicates that aripiprazole and quetiapine protect enzyme activity from inhibition with hydrogen peroxide. Our results showed that sertindole decreases activity of CAT comparing with control non-treated erythrocytes. Moreover, in sertindole treated erythrocytes, negative correlation between SOD1 and glutathione peroxidase activities was found. Increased amount of hydrogen peroxide in such situation may leave erythrocytes and transform their role in circulation from anti-oxidative to pro-oxidative.
CONCLUSIONS: Our results indicate that mechanism through sertindole could express its in vivo toxic effects and point toward possible (neuro)protective effects of aripiprazole and quetiapine.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23124725     DOI: 10.1002/hup.2272

Source DB:  PubMed          Journal:  Hum Psychopharmacol        ISSN: 0885-6222            Impact factor:   1.672


  6 in total

1.  Aripiprazole an atypical antipsychotic protects against ethanol induced gastric ulcers in rats.

Authors:  Abdulrahman Al Asmari; Mohammed Arshaduddin; Ibrahim Elfaki; Saeed Kadasah; Abdulrahman Al Robayan; Saeed Al Asmary
Journal:  Int J Clin Exp Med       Date:  2014-08-15

2.  Aripiprazole increases NAD(P)H-quinone oxidoreductase-1 and heme oxygenase-1 in PC12 cells.

Authors:  Yoko S Kaneko; Takeshi Takayanagi; Hiroshi Nagasaki; Yu Kodani; Akira Nakashima; Keiji Mori; Atsushi Suzuki; Mitsuyasu Itoh; Kazunao Kondo; Toshiharu Nagatsu; Miyuki Ota; Akira Ota
Journal:  J Neural Transm (Vienna)       Date:  2014-12-14       Impact factor: 3.575

3.  Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review).

Authors:  Márcio G Soeiro-DE-Souza; Vasco Videira Dias; Giovanni Missio; Vicent Balanzá-Martinez; Leandro Valiengo; André F Carvalho; Ricardo Alberto Moreno
Journal:  Exp Ther Med       Date:  2015-01-23       Impact factor: 2.447

4.  Longer Telomere Length of T lymphocytes in Patients with Early and Chronic Psychosis.

Authors:  Yin Cui; Vishwanath Vasudev Prabhu; Thong Ba Nguyen; Subramaniam Mohana Devi; Young-Chul Chung
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-05-31       Impact factor: 2.582

5.  Potentiating and synergistic effect of grapefruit juice on the antioxidant and anti-inflammatory activity of aripiprazole against hydrogen peroxide induced oxidative stress in mice.

Authors:  Seema Zargar; Abdul-Rahman A Al-Majed; Tanveer A Wani
Journal:  BMC Complement Altern Med       Date:  2018-03-23       Impact factor: 3.659

6.  Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients.

Authors:  Takeshi Fukushima; Hideaki Iizuka; Ayaka Yokota; Takehiro Suzuki; Chihiro Ohno; Yumiko Kono; Minami Nishikiori; Ayaka Seki; Hideaki Ichiba; Yoshinori Watanabe; Seiji Hongo; Mamoru Utsunomiya; Masaki Nakatani; Kiyomi Sadamoto; Takashi Yoshio
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.